rESWT vs LLLT for Cervical Myofascial Pain
16 de mayo de 2026 actualizado por: Tirza Z Tamin, Indonesia University
Radial Extracorporeal Shockwave Therapy vs Low-Level Laser Therapy for Cervical Myofascial Pain Syndrome in Adults: A Randomized Controlled Trial
Background and Aim: Myofascial pain syndrome (MPS) in the cervical region is one of the most common musculoskeletal disorders associated with myofascial trigger points that cause muscle pain, stiffness, and reduced range of motion, precipitated by forward head posture.
Many non-invasive modalities, including low-level laser therapy (LLLT) and extracorporeal shockwave therapy (ESWT), have been reported to reduce symptoms.
However, comparative effectiveness of these interventions remains unclear.
This study aimed to compare the effectiveness of radial ESWT and LLLT in reducing pain and improving functional outcomes in patients with cervical MPS among the working-age adults.
Methods: A randomized controlled study was conducted in a working-age adults with MPS.
Fifty subjects, divided in two groups received either ESWT or LLLT.
Numeric rating scale (NRS), cervical range of motion (ROM), and craniovertebral angle (CVA) were assessed before and throughout three weeks post intervention.
Results: Both LLLT and ESWT showed significant (p < 0.001) changes in NRS, cervical ROM, and CVA.
LLLT showed a difference in pain reduction at week three (p < 0.001) and flexion and extension ROM at week two and three (p < 0.05).
Conclusion: LLLT demonstrated superior results in pain reduction at the three-week mark and produced greater increases in cervical flexion and extension ROM during the two- and three-week periods when compared with ESWT.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
50
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
DKI Jakarta
-
Jakarta Pusat, DKI Jakarta, Indonesia, 10430
- Universitas Indonesia, Cipto Mangunkusumo General Hospital
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- men and women
- aged 18 to 59 years old
- sedentary activity level
- active MTrP on the upper trapezius muscle
- moderate pain with an NRS pain score of 4-7
- restriction of ROM
- CVA angle of ≤ 50°
- All agreed to participate in this study with informed consent.
Exclusion Criteria:
- patients who were unable to complete the assessment or communicate adequately based on the Indonesian version of Montreal Cognitive Assessment (MoCA-Ina)
- experiencing neck pain caused by radicular syndrome proven with the Spurling test, distraction test and Adson test.
- history of malignancy
- history of blood clotting disorder
- receiving anticoagulant therapy
- in a emergency state (e.g., loss of consciousness, shortness of breath, active bleeding, seizures, or hyperpyrexia)
- pregnant
- participants with pacemaker
- participants undergoing other treatments (manual therapy, massage, acupuncture, dry needling, or other rehabilitation modalities) for neck pain in the previous two weeks
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Radial Extracorporeal Shockwave Therapy
The first group intervened with ESWT BTL-5000 SWR radial 2000-4000 pulse per session, once a week, for a duration of 10-60 minutes, for three weeks.
ESWT was applied to MTrPs bilaterally at 2.5 bar, with a frequency of up to 10 Hz and an energy flux density of 0.05-0.35
mJ/mm².
Ultrasound gel was applied to the skin where ESWT probes were attached.
|
The first group intervened with ESWT BTL-5000 SWR radial 2000-4000 pulse per session, once a week, for a duration of 10-60 minutes, for three weeks.
ESWT was applied to MTrPs bilaterally at 2.5 bar, with a frequency of up to 10 Hz and an energy flux density of 0.05-0.35
mJ/mm².
Ultrasound gel was applied to the skin where ESWT probes were attached.
Otros nombres:
|
|
Comparador activo: Low-Level Laser Therapy
The second group received LLLT with BTL 4000 a total of six times, given twice a week.
LLLT was applied to palpated active MTrPs at a dose of 40-50 J and an average power of 100 mW.
|
The second group received LLLT with BTL 4000 a total of six times, given twice a week.
LLLT was applied to palpated active MTrPs at a dose of 40-50 J and an average power of 100 mW
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Pain Intensity Changes (Numeric Rating Scale)
Periodo de tiempo: 3 weeks
|
NRS is an instrument to evaluate pain subjectively, with 11 scores of pain, ranging from 0 "no pain" to 10 "worst pain possible."
Pain intensity categorized into mild (0-3), moderate (4-6), and severe (>7).
Participants must be fully conscious, mentally competent, and able to communicate verbally.
MCID in the NRS score is 1.3.21
|
3 weeks
|
|
Cervical Range of Motion
Periodo de tiempo: 3 weeks
|
Cervical ROM was used to detect movement dysfunction on patients' necks.
Limitation of ROM can be caused by pain, muscle shortening, and other structural problems.
ROM was measured with a goniometer.22
Patients were positioned to measure neck flexion, extension, lateral bending, and rotation.
The examiner then measured the angle formed.
Normal ranges are 1) flexion: 45.9-46.8°,
2) extension: 42.7-47.4°,
3) rotation to right: 63.3-67.2°,
4) rotation to left: 65.7-67.8°,
5) lateral flexion to right: 31.5-34.9°,
and 6) lateral flexion to left: 31.4-36.6°.23
|
3 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Craniovertebral angle
Periodo de tiempo: 3 weeks
|
CVA is defined as the angle between a horizontal line passing through the C7 spinous process and a line connecting C7 to the tragus.
A smaller CVA indicates greater anterior head displacement and increases the risk of forward head posture.
The normal value is > 50°, while forward head posture has a CVA of < 50°.
Outcome analysis was conducted based on the change from baseline values, evaluated at baseline, in Weeks 1, 2, and 3 after treatment.
|
3 weeks
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Tirza Z Tamin, MD, Indonesia University
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de octubre de 2024
Finalización primaria (Actual)
30 de agosto de 2025
Finalización del estudio (Actual)
1 de septiembre de 2025
Fechas de registro del estudio
Enviado por primera vez
12 de mayo de 2026
Primero enviado que cumplió con los criterios de control de calidad
12 de mayo de 2026
Publicado por primera vez (Actual)
18 de mayo de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
19 de mayo de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
16 de mayo de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- ESWT vs LLLT in Cervical MPS
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .